This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Sysco Buys Doerle Food Services to Widen Distribution in US
by Zacks Equity Research
Sysco (SYY) has acquired Doerle Food Services, a Louisiana-based food service distributor. This buyout is likely to strengthen the company's core business and drive growth.
Hormel Foods (HRL) to Post Q1 Earnings: A Beat in Store?
by Zacks Equity Research
Strategic acquisitions, elevated demand for iconic brands and increased advertising moves to boost Hormel Food's (HRL) bottom-line performance in first-quarter fiscal 2018.
Can the Comeback Continue?
by James Giaquinto
Can the Comeback Continue?
Boston Beer's (SAM) Q4 Earnings to Gain From Growth Plan
by Zacks Equity Research
Boston Beer (SAM) is banking on its three-point growth-plan to lift performance. This is likely to aid performance in fourth-quarter 2017.
Fluor (FLR) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Recent EPC awards expected to drive Fluor's (FLR) top-line growth in the to-be-reported quarter.
Will Weak End Markets Dent Flowserve's (FLS) Q4 Earnings?
by Zacks Equity Research
Flowserve's (FLS) fourth-quarter 2017 results are likely to be hurt by lower original equipment sales in key end markets.
Can Robust Strategies Fuel Nu Skin's (NUS) Q4 Earnings?
by Zacks Equity Research
Nu Skin (NUS) has been progressing well with the execution of its growth strategy. Also, the company remains focused on the expansion of the customer base and sales leaders.
Molson Coors (TAP) Q4 Earnings Likely to Rise Y/Y: Here's Why
by Zacks Equity Research
Molson Coors (TAP) has been gaining from growth of its above-premium segment. Even amid tough North American conditions, the company remains on track to achieve its financial goals for 2017.
The Super Bowl Is Over, But You Can Still Buy These 3 Sin Stocks
by Benjamin Rains
Super Bowl LII in Minneapolis turned out to be a fantastic game between the Philadelphia Eagles and the New England Patriots. And while the teams battled it out on the field in historic high-scoring fashion, people around the country gathered in living rooms and bars happily sipping their favorite adult beverages.
Church & Dwight (CHD) Beats on Q4 Earnings, Guides for FY18
by Zacks Equity Research
Church & Dwight Company (CHD) posted mixed fourth-quarter 2017 results, wherein earnings topped estimates while sales lagged. However, both top and bottom lines grew year over year.
Clorox (CLX) Beats on Q2 Earnings, Raises FY18 EPS View
by Zacks Equity Research
The Clorox Company (CLX) posted robust second-quarter fiscal 2018 earnings per share which beat estimates, while revenues lagged the same.
Colgate (CL) Stock Falls on Flat Q4 Earnings and Sales Lag
by Zacks Equity Research
Colgate-Palmolive Co. (CL) posted adjusted earnings of 75 cents a share in fourth-quarter 2017, in line with the Zacks Consensus Estimate and flat with the prior-year quarter.
Archer Daniels' (ADM) New Innovation Center to Woo Customers
by Zacks Equity Research
Archer Daniels (ADM) opens a new innovation center in Singapore in order to be more accessible to its customers. This is likely to strengthen its footprint in Southeast Asia.
Why Should You Buy Energizer Post Spectrum Asset Buyout Plan
by Zacks Equity Research
Energizer (ENR) plans to acquire the battery and portable lighting business of Spectrum Brands (SPB) for $2 billion.
Tough Industry Hurt Archer Daniels (ADM) Stock: What's Ahead?
by Zacks Equity Research
Archer Daniels Midland Company (ADM) has been in soup due to the tough operating environment in the Agricultural industry stemming from fluctuating commodity prices and oversupply in the industry.
5 Reasons Why Clorox (CLX) is a Must Add Stock Right Now
by Zacks Equity Research
The Clorox Inc. (CLX) stock has been moving up the charts, thanks to the smooth execution of its 2020 strategy. By its actions, the company is poised to boost growth for its categories as well as overall market share.
Will Boston Beer's Efforts to Drive Long-Term Growth Succeed?
by Zacks Equity Research
Boston Beer (SAM) is gaining from its strategic initiatives, cost savings, innovations and acquisitions, amid tough competition and soft depletions.
The Zacks Analyst Blog Highlights: Innovative Industrial Properties, Constellation Brands, Boston Beer, British American Tobacco and Las Vegas Sands
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Innovative Industrial Properties, Constellation Brands, Boston Beer, British American Tobacco and Las Vegas Sands
Colgate (CL) Loses 13.9% YTD: What's Hurting the Stock?
by Zacks Equity Research
Colgate-Palmolive Company (CL) has been witnessing immense pressure of late.This is reflected in the company's strained margins and recently raised cost guidance pertaining to its Global Growth & Efficiency Program.
Zacks.com highlights: G-III Apparel Group, Michael Kors Holdings, Magellan Health, Boston Beer and FTI Consulting
by Zacks Equity Research
Zacks.com highlights: G-III Apparel Group, Michael Kors Holdings, Magellan Health, Boston Beer and FTI Consulting
Market Volatility is Not a Concern: Buy 5 Low-Beta Stocks
by Zacks Equity Research
Our investment strategy clearly shows that lucrative returns can also be generated from playing less risky stocks.
Zacks.com featured highlights: WellCare Health Plans, Boston Beer Company, AppFolio, TriNet Group and Urban Outfitters
by Zacks Equity Research
Zacks.com featured highlights: WellCare Health Plans, Boston Beer Company, AppFolio, TriNet Group and Urban Outfitters
5 Top Liquid Stocks for a Winning Portfolio
by Zacks Equity Research
Liquidity primarily indicates a company's capability to meet debt obligations by converting assets into liquid cash and equivalents.
Zacks.com featured highlights: Skechers U.S.A., Boston Beer Company, Pilgrim's Pride, Movado and Triple-S Management
by Zacks Equity Research
Zacks.com featured highlights: Skechers U.S.A., Boston Beer Company, Pilgrim's Pride, Movado and Triple-S Management
Include 5 Low-Beta Stocks & Nullify Market Volatility
by Zacks Equity Research
Our intense research has developed a strategy that allows investors to spend money on securities with lower risk that fetch attractive returns.